Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The applications segment of the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered by multiplex assays are driving the growth of this segment. North America is expected to account for the largest share of the multiplex assays market in 2016. This region is estimated to account for 44.7% of the total market. Europe is the second-largest source, this regional market is driven by the availability of government funds. Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=61593314 The adoption of companion diagnostics for increasing safety & efficacy of therapies, need for effective analytical platforms in research to reduce operational costs, advantage

The report  “ Inorganic Scintillators Market  by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) – Analysis & Global Forecast to 2021″ , This report studies the global inorganic scintillators market for the forecast period of 2016 to 2021. This market is expected to reach USD 330.7 Million by 2021 from USD 256.1 Million in 2016, growing at a CAGR of 5.2%. The global inorganic scintillators market is segmented on the basis of scintillation material, type, application, and region. Browse 76 market data Tables and 49 Figures spread through 165 Pages and in-depth TOC on  “Inorganic Scintillators Market by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) – Analysis & Global Forecast to 2021”   http://www.m

The report “ Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) – Global Forecast to 2022″ , The PDX models market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%. The key factors driving the growth of this market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market. Browse 44 Market Data Tables and 34 Figures spread through 148 Pages and in-depth TOC on “Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respir